Iris Appelmann
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
-
- Chronic Myeloid Leukemia Treatments 4
- Genetics 6
- Chronic Lymphocytic Leukemia Research 4
- Myeloproliferative Neoplasms: Diagnosis and Treatment 2
- Co-authors
- Wolfgang E. Berdel (6 shared papers)Rolf Michael Mesters (5 shared papers)Scott Lowe (5 shared papers)Rüediger Liersch (3 shared papers)Torsten Keßler (3 shared papers)Cornelius Miething (3 shared papers)Claudio Scuoppo (3 shared papers)Julie Teruya‐Feldstein (2 shared papers)
- Journals
- Blood (4 papers)Annals of Hematology (3 papers)BMC Palliative Care (2 papers)Nature (2 papers)BMC Cancer (2 papers)
- Partner nations
- GermanyUnited StatesCanada
In The Last Decade
Iris Appelmann
21 papers receiving 485 citations
Peers
Comparison fields: 5 of 68
- Hematology 116
- Genetics 81
- Cancer Research 48
- Molecular Biology 232
- Biochemistry 22
Countries citing papers authored by Iris Appelmann
This map shows the geographic impact of Iris Appelmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Appelmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Appelmann more than expected).
Fields of papers citing papers by Iris Appelmann
This network shows the impact of papers produced by Iris Appelmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Appelmann. The network helps show where Iris Appelmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Iris Appelmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 114 | |
| 2 | 2009 | 61 | |
| 3 | 2012 | 55 | |
| 4 | 2010 | 39 | |
| 5 | 2014 | 38 | |
| 6 | 2014 | 34 | |
| 7 | 2016 | 34 | |
| 8 | 2022 | 25 | |
| 9 | 2011 | 23 | |
| 10 | 2018 | 18 | |
| 11 | 2019 | 15 | |
| 12 | 2020 | 11 | |
| 13 | 2009 | 7 | |
| 14 | 2024 | 5 | |
| 15 | 2010 | 3 | |
| 16 | 2023 | 2 | |
| 17 | 2024 | 2 | |
| 18 | 2025 | 2 | |
| 19 | 2014 | 1 | |
| 20 | 2020 | 1 |
About Iris Appelmann
Iris Appelmann is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Rheumatology and Oncology, having authored 24 papers that have together received 491 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (5 papers), Chronic Myeloid Leukemia Treatments (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Palliative Care and End-of-Life Issues (4 papers), Health and Medical Studies (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Childhood Cancer Survivors' Quality of Life (2 papers) and Cancer-related gene regulation (2 papers). The work is most often cited by research in Hematology (116 citations), Genetics (81 citations), Cancer Research (48 citations), Molecular Biology (232 citations) and Biochemistry (22 citations). Iris Appelmann has collaborated with scholars based in Germany, United States and Canada. Frequent co-authors include Wolfgang E. Berdel, Rolf Michael Mesters, Scott Lowe, Rüediger Liersch, Torsten Keßler, Cornelius Miething, Claudio Scuoppo, Julie Teruya‐Feldstein, Lisa Lindqvist and Darryl J Pappin. Their work appears in journals such as Blood, Annals of Hematology, BMC Palliative Care, Nature and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.